arrow
返回
C

Carl C. Peck

University of California System

37H指数
160论文数
4.9K被引数
收录论文 35
发表时间
Bioequivalence of ANDA Data using a Non-Informative Bayesian Procedure (BEST) Compared with the Two One-Sided t-Tests (TOST)
err2025-02-19
err0
PREAI
errWang, Jing; Campbell, Gregory; Lee, Jae H.; Hu, Meng; Feng, Kairui; Chattopadhyay, Somesh; Zhao, Liang; Peck, Carl C.
err分享
err收藏
Strength of clinical evidence supporting the United States Food and Drug Administration Accelerated Approvals from 2015 to 2022
err2024-12-18
err0
errOAAI
errZhang, Xiaofang; Peck, Carl C.; Wang, Yaning; Szucs, Thomas D.; Sun, Wan; Bai, Xue; Chen, Siyu; Wang, Fengzhi; Wu, Yangfeng
err分享
err收藏
The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA
err2024-02-27
err8
PREAI
errFang, Lanyan; Gong, Yuqing; Hooker, Andrew C.; Lukacova, Viera; Rostami-Hodjegan, Amin; Sale, Mark; Grosser, Stella; Jereb, Rebeka; Savic, Rada; Peck, Carl; Zhao, Liang
err分享
err收藏
Comparing a Bayesian Approach (BEST) with the Two One-Sided t-Tests (TOSTs) for Bioequivalence Studies
err2022-09-01
err2
errOAAI
errPeck, Carl; Campbell, Gregory; Yoo, Isaac; Feng, Kairui; Hu, Meng; Zhao, Liang
err分享
err收藏
err分享
err收藏
Scientific considerations for global drug development
err2020-07-29
err8
errOAAI
errWilson, Jennifer L.; Cheung, Kit Wun Kathy; Lin, Lawrence; Green, Elizabeth A. E.; Porras, Analia, I; Zou, Ling; Mukanga, David; Akpa, Paul A.; Darko, Delese Mimi; Yuan, Rae; Ding, Sheng; Johnson, Wiltshire C. N.; Lee, Howard A.; Cooke, Emer; Peck, Carl C.; Kern, Steven E.; Hartman, Dan; Hayashi, Yoshikazu; Marks, Peter W.; Altman, Russ B.; Lumpkin, Murray M.; Giacomini, Kathleen M.; Blaschke, Terrence F.
err分享
err收藏
err分享
err收藏
At the end of the beginning: immunotherapies as living drugs (vol 20, pg 955, 2019)
err2019-08-06
err1
errOAAI
errFeigal, Ellen G.; DeWitt, Natalie D.; Cantilena, Cathy; Peck, Carl; Stroncek, David
err分享
err收藏
At the end of the beginning: immunotherapies as living drugs
err2019-07-15
err8
PREAI
errFeigal, Ellen G.; DeWitt, Natalie D.; Cantilena, Cathy; Peck, Carl; Stroncek, David
err分享
err收藏
err分享
err收藏
Poor medication adherence in clinical trials: consequences and solutions COMMENT
err2017-02-03
err60
PREAI
errBreckenridge, Alasdair; Aronson, Jeffrey K.; Blaschke, Terrence F.; Hartman, Dan; Peck, Carl C.; Vrijens, Bernard
err分享
err收藏
Efficacy of 17α-ethynylestradiol-3-sulfate for severe hemorrhage in minipigs in the absence of fluid resuscitation
err2014-06-01
err26
PREAI
errMiller, Matthew; Keith, James; Berman, Jonathan; Burlington, D. Bruce; Grudzinskas, Charles; Hubbard, William; Peck, Carl; Scott, Charles; Chaudry, Irshad H.
err分享
err收藏
Impact of the pharmaceutical sciences on health care: A reflection over the past 50 years
err2012-11-01
err36
PREAI
errRowland, Malcolm; Noe, Christian R.; Smith, Dennis A.; Tucker, G. T.; Crommelin, Daan J. A.; Peck, Carl C.; Rocci, Mario L., Jr.; Besancon, Luc; Shah, Vinod P.
err分享
err收藏
A roadmap for biomarker qualification
err2010-05-01
err67
PREAI
errWarnock, David G.; Peck, Carl C.
err分享
err收藏
Recommended changes to oncology clinical trial design: Revolution or evolution?
err2008-01-01
err31
errOAAI
errRatain, Mark J.; Humphrey, Rachel W.; Gordon, Gary B.; Fyfe, Gwen; Adamson, Peter C.; Fleming, Thomas R.; Stadler, Walter M.; Berry, Donald A.; Peck, Carl C.
err分享
err收藏